| Objective To observe the efficacy of strong-bone decoction on refractures after the elder femoral intertrochanter fracture in the opposite side. Methods Data of 120 elder patients with intertrochanter fractures operated in our department from January 2016 to December 2016 were collected. The patients were randomly divided to routine recovery group, basic medicine group, and strong-bone decoction group, with 40 patients in each group. Patients in routine recovery group received routine fracture recovery treatment. In other two groups, patients received additional Caltrate D and Alfacalcidol capsules. Patients in strong-bone decoction group received strong-bone decoction granules. The patients were followed up for 1 year. The incidence of fracture and bone mineral density (BMD) of the opposite intertrochanter and femoral neck before and after femoral intertrochanter fracture in the 3 groups was recorded and compared. Results One hundred and five patients were followed, and fifteen were lost. There were 4 refractures in 1 year, including 3 cases in routine recovery group, 1 case in basic medicine group, and 0 in strong-bone decoction group. The incidence of refracture was 8.57%, 2.85%, and 0%, respectively. Strong-bone decoction group was better than the other 2 groups, but the difference was not significant (P>0.05). After 1-year treatment, BMD of the intertrochanter and femoral neck was 0.672±0.052 g/m2 and 0.574±0.063 g/m2, respectively, which was higher than that in routine recovery group (P<0.05) and basic medicine group (P>0.05). Conclusion Strong-bone decoction increases BMD of the opposite intertrochanter and femoral neck after femoral intertrochanter fracture in the elderly, increases bone strength, and effectively decreases fracture risk of the opposite intertrochanter. |